Loading...
XMAD
PRM
Market cap181mUSD
Apr 09, Last price  
9.50EUR
1D
-1.45%
1Q
-2.46%
Jan 2017
6.74%
Name

Prim SA

Chart & Performance

D1W1MN
P/E
12.75
P/S
0.75
EPS
0.74
Div Yield, %
3.55%
Shrs. gr., 5y
-0.37%
Rev. gr., 5y
10.00%
Revenues
217m
+9.77%
64,494,03371,953,99190,542,33291,630,05295,760,93795,496,61895,111,84091,446,38488,662,28387,000,32794,205,58299,227,781110,099,596121,272,878134,429,946150,998,844147,323,948168,512,431197,245,073216,510,625
Net income
13m
+51.02%
4,744,2515,710,8347,554,94710,060,2179,903,88910,034,9228,531,9608,908,8609,135,1439,634,2689,961,52710,702,84713,096,66213,897,88114,118,96311,218,1256,917,30117,422,5908,391,26812,672,570
CFO
-31m
L
0000000000012,245,80611,596,29512,438,4136,574,479652,23725,958,90526,304,7934,889,666-31,245,065
Dividend
Jul 17, 20240.2269 EUR/sh

Profile

Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
URL
https://www.prim.es/
IPO date
Jan 21, 1997
Employees
827
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
216,511
9.77%
197,245
17.05%
Cost of revenue
136,911
128,850
Unusual Expense (Income)
NOPBT
79,600
68,395
NOPBT Margin
36.76%
34.68%
Operating Taxes
4,353
2,482
Tax Rate
5.47%
3.63%
NOPAT
75,247
65,913
Net income
12,673
51.02%
8,391
-51.84%
Dividends
(6,239)
(8,839)
Dividend yield
3.51%
4.80%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
16,964
10,279
Long-term debt
15,226
18,576
Deferred revenue
2
550
Other long-term liabilities
1,295
2,924
Net debt
12,640
10,738
Cash flow
Cash from operating activities
(31,245)
4,890
CAPEX
(10,390)
Cash from investing activities
(4,204)
Cash from financing activities
30,369
FCF
63,156
48,934
Balance
Cash
13,248
14,941
Long term investments
6,301
3,176
Excess cash
8,724
8,255
Stockholders' equity
128,450
128,069
Invested Capital
143,819
136,399
ROIC
53.71%
54.37%
ROCE
51.37%
46.86%
EV
Common stock shares outstanding
17,010
17,060
Price
10.45
-3.24%
10.80
-25.77%
Market cap
177,757
-3.52%
184,244
-26.47%
EV
193,268
194,981
EBITDA
89,643
76,772
EV/EBITDA
2.16
2.54
Interest
826
281
Interest/NOPBT
1.04%
0.41%